Medifast (MED) is proactively positioning itself to tap into the increasing demand for weight loss medications, showcasing a commitment to staying in touch with market trends.
Dividend growth stocks often provide reliable cash flows and long-term wealth for income investors. Screening dividend stocks based on safety, growth, and consistency can be beneficial to find new opp
Medifast's (MED) Q3 results reflect challenges in customer acquisition. However, cost-reduction efforts and efficiency improvements as part of the "Fuel for the Future" plan bode well.
Medifast, Inc. (NYSE:MED ) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Steven Zenker - Vice President of Investor Relations Dan Chard - Chairman and Chief Executi
Medifast's (MED) third-quarter results are likely to reflect concerns surrounding customer acquisition amid a challenging landscape. However, a focus on growth plans bodes well.

New Strong Sell Stocks for October 12th

08:16am, Thursday, 12'th Oct 2023
BGS, MS and MED have been added to the Zacks Rank #5 (Strong Sell) List on October 12, 2023.
Consumer staples NYSEARCA: XLP stocks are down 6.5% from their July highs and more than 10% from the 2022 peaks and may move lower. The caveat is that the sector is trading near the bottom of a range,
Medifast's (MED) OPTAVIA program is a robust and adaptable solution focused on health and wellness. This holistic approach positions it for sustained long-term growth.
Medifast (MED) reported earnings 30 days ago. What's next for the stock?
British American Tobacco and Medifast each could have solid growth ahead. Both companies' payouts appear to be viable moving forward.
U.S. credit rating cut by Fitch, inflation trending down and the Fed raising interest rates by another 25 basis points have been the headlines since our last month's article. That being said, life and
Medifast's (MED) second-quarter 2023 results reflect lower sales and earnings on reduced Coach productivity and cost inflation.
Medifast (MED) came out with quarterly earnings of $2.77 per share, beating the Zacks Consensus Estimate of $1.44 per share. This compares to earnings of $3.87 per share a year ago.
Medifast, Inc. (NYSE:MED ) Q2 2023 Earnings Conference Call August 7, 2023 4:30 PM ET Company Participants Steve Zenker - VP of IR Dan Chard - Chairman and CEO Jim Maloney - CFO Conference Call Partic
Medifast has seen a significant decline in its stock price and market cap in the past 2 years, reflecting investors' pessimism towards the company. The stock's underperformance may be attributed to in
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE